• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    1.40 Down 0.11(7.28%) Apr 29, 4:00PM EDT
    |After Hours : 1.39 Down 0.01 (0.71%) Apr 29, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 1,739   1,454   809  
    Cost of Revenue -   -   -  
    Gross Profit 1,739   1,454   809  
    Operating Expenses
    Research Development103,120  85,637  43,906  
    Selling General and Administrative24,903  16,960  12,377  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (126,284) (101,143) (55,474)
    Income from Continuing Operations
    Total Other Income/Expenses Net15,696  (33,495)(9,473)
    Earnings Before Interest And Taxes(110,588)(134,638)(64,947)
    Interest Expense4,153  996  842  
    Income Before Tax(114,741)(135,634)(65,789)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(114,741)(135,634)(65,789)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (114,741) (135,634) (65,789)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (114,741) (135,634) (65,789)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.